← FDA Drug Approvals (Drugs@FDA)
LIDOCAINE HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ASPIRO · Approved 2021-11-08
Drug application
- FDA Application #
ANDA214336- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LIDOCAINE HYDROCHLORIDE
- Generic name
- LIDOCAINE HYDROCHLORIDE
- Active ingredients
- LIDOCAINE HYDROCHLORIDE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- ASPIRO
- Manufacturer
- Camber Pharmaceuticals, Inc.
- First approval
- 2021-11-08
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown